7-octadecynoic acid

7-octadecynoic acid is a lipid of Fatty Acyls (FA) class.

Cross Reference

There are no associated biomedical information in the current reference collection.

Current reference collection contains 19785 references associated with 7-octadecynoic acid in LipidPedia. Due to lack of full text of references or no associated biomedical terms are recognized in our current text-mining method, we cannot extract any biomedical terms related to diseases, pathways, locations, functions, genes, lipids, and animal models from the associated reference collection.

Users can download the reference list at the bottom of this page and read the reference manually to find out biomedical information.


Here are additional resources we collected from PubChem and MeSH for 7-octadecynoic acid

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with 7-octadecynoic acid

MeSH term MeSH ID Detail
Mandibular Diseases D008336 5 associated lipids
Bone Resorption D001862 7 associated lipids
Foreign-Body Reaction D005549 10 associated lipids
Arthritis D001168 41 associated lipids
Arthritis, Experimental D001169 24 associated lipids
Bone Neoplasms D001859 5 associated lipids
Fractures, Bone D050723 4 associated lipids
Osteoarthritis D010003 4 associated lipids
Carcinoma D002277 18 associated lipids
Osteonecrosis D010020 5 associated lipids
Per page 10 20 50 100 | Total 298

All references with 7-octadecynoic acid

Download all related citations
Per page 10 20 50 100 | Total 4091
Authors Title Published Journal PubMed Link
da Silva TA et al. Comparative expression of RANK, RANKL, and OPG in keratocystic odontogenic tumors, ameloblastomas, and dentigerous cysts. 2008 Oral Surg Oral Med Oral Pathol Oral Radiol Endod pmid:18061491
Andrade FR et al. Expression of bone resorption regulators (RANK, RANKL, and OPG) in odontogenic tumors. 2008 Oral Surg Oral Med Oral Pathol Oral Radiol Endod pmid:18928898
He J et al. Emdogain promotes osteoblast proliferation and differentiation and stimulates osteoprotegerin expression. 2004 Oral Surg Oral Med Oral Pathol Oral Radiol Endod pmid:14970783
Kawashima N et al. Kinetics of RANKL, RANK and OPG expressions in experimentally induced rat periapical lesions. 2007 Oral Surg Oral Med Oral Pathol Oral Radiol Endod pmid:17336108
Giorgetti AP et al. Cigarette smoke inhalation modulates gene expression in sites of bone healing: a study in rats. 2010 Oral Surg Oral Med Oral Pathol Oral Radiol Endod pmid:20573527
Kaneyama K et al. Expression of osteoprotegerin in synovial tissue and degradation of articular cartilage: comparison with arthroscopic findings of temporomandibular joint disorders. 2003 Oral Surg Oral Med Oral Pathol Oral Radiol Endod pmid:12973279
Pérez-Sayáns M et al. RANK/RANKL/OPG role in distraction osteogenesis. 2010 Oral Surg Oral Med Oral Pathol Oral Radiol Endod pmid:20163972
Elias LS et al. Markers of bone remodeling in neoplastic and bone-related lesions. 2010 Oral Surg Oral Med Oral Pathol Oral Radiol Endod pmid:20955951
Qu Z et al. Effect of enamel matrix derivative on proliferation and differentiation of osteoblast cells grown on the titanium implant surface. 2011 Oral Surg Oral Med Oral Pathol Oral Radiol Endod pmid:21232997
Ichimiya H et al. Compressive mechanical stress promotes osteoclast formation through RANKL expression on synovial cells. 2007 Oral Surg Oral Med Oral Pathol Oral Radiol Endod pmid:17321443
Kawasaki K et al. Effects of aging on RANKL and OPG levels in gingival crevicular fluid during orthodontic tooth movement. 2006 Orthod Craniofac Res pmid:16918678
Fujita S et al. Low-energy laser stimulates tooth movement velocity via expression of RANK and RANKL. 2008 Orthod Craniofac Res pmid:18713151
Zhao N et al. Effects of local osteoprotegerin gene transfection on orthodontic root resorption during retention: an in vivo micro-CT analysis. 2012 Orthod Craniofac Res pmid:22264323
Nishijima Y et al. Levels of RANKL and OPG in gingival crevicular fluid during orthodontic tooth movement and effect of compression force on releases from periodontal ligament cells in vitro. 2006 Orthod Craniofac Res pmid:16764680
Dorotheou D et al. Tooth eruption: altered gene expression in the dental follicle of patients with cleidocranial dysplasia. 2013 Orthod Craniofac Res pmid:23311656
Tan YY et al. Effects of vascular endothelial growth factor (VEGF) on MC3T3-E1. 2010 Orthod Craniofac Res pmid:21040465
George A and Evans CA Detection of root resorption using dentin and bone markers. 2009 Orthod Craniofac Res pmid:19627525
Hartsfield JK Pathways in external apical root resorption associated with orthodontia. 2009 Orthod Craniofac Res pmid:19627526
Yamaguchi M RANK/RANKL/OPG during orthodontic tooth movement. 2009 Orthod Craniofac Res pmid:19419454
El Hadj Othmane T et al. [Osteoprotegerin: regulator, protector and marker]. 2008 Orv Hetil pmid:18842549
Kovács G et al. [Metabolic differences in healthy first-degree female relatives of type 2 diabetic patients]. 2013 Orv Hetil pmid:24161599
Rutges JP et al. Hypertrophic differentiation and calcification during intervertebral disc degeneration. 2010 Osteoarthr. Cartil. pmid:20723612
Sanchez C et al. Mechanical loading highly increases IL-6 production and decreases OPG expression by osteoblasts. 2009 Osteoarthr. Cartil. pmid:18974013
Bellido M et al. Improving subchondral bone integrity reduces progression of cartilage damage in experimental osteoarthritis preceded by osteoporosis. 2011 Osteoarthr. Cartil. pmid:21820069
Liu YD et al. Systemic administration of strontium or NBD peptide ameliorates early stage cartilage degradation of mouse mandibular condyles. 2016 Osteoarthr. Cartil. pmid:26256766
Pantsulaia I et al. Association between radiographic hand osteoarthritis and RANKL, OPG and inflammatory markers. 2010 Osteoarthr. Cartil. pmid:20633673
Liu YD et al. Reducing dietary loading decreases mouse temporomandibular joint degradation induced by anterior crossbite prosthesis. 2014 Osteoarthr. Cartil. pmid:24316289
Pecchi E et al. A potential role of chondroitin sulfate on bone in osteoarthritis: inhibition of prostaglandin E₂ and matrix metalloproteinases synthesis in interleukin-1β-stimulated osteoblasts. 2012 Osteoarthr. Cartil. pmid:22179028
Sheng ZF et al. Zoledronate reverses mandibular bone loss in osteoprotegerin-deficient mice. 2009 Osteoporos Int pmid:18496637
Ermakov S et al. A significant association exists between receptor tyrosine kinase-like orphan receptor 2 gene variants and the OPG/RANKL ratio in human plasma. 2012 Osteoporos Int pmid:22057548
Hampson G et al. Effects of dietary improvement on bone metabolism in elderly underweight women with osteoporosis: a randomised controlled trial. 2003 Osteoporos Int pmid:12904840
Dobnig H et al. Changes in the RANK ligand/osteoprotegerin system are correlated to changes in bone mineral density in bisphosphonate-treated osteoporotic patients. 2006 Osteoporos Int pmid:16435076
Kananen K et al. Serum osteoprotegerin and receptor activator of nuclear factor-kappaB ligand (RANKL) concentrations in allogeneic stem cell transplant-recipients: a role in bone loss? 2006 Osteoporos Int pmid:16437190
Xie H et al. Omentin-1 exerts bone-sparing effect in ovariectomized mice. 2012 Osteoporos Int pmid:21755404
Nakashima A et al. Plasma osteoprotegerin, arterial stiffness, and mortality in normoalbuminemic Japanese hemodialysis patients. 2011 Osteoporos Int pmid:20812007
Khosla S et al. Correlates of osteoprotegerin levels in women and men. 2002 Osteoporos Int pmid:12086350
D'Amelio P et al. Bone and bone marrow pro-osteoclastogenic cytokines are up-regulated in osteoporosis fragility fractures. 2011 Osteoporos Int pmid:21116815
Zhang Y et al. Study of the mechanisms by which Sambucus williamsii HANCE extract exert protective effects against ovariectomy-induced osteoporosis in vivo. 2011 Osteoporos Int pmid:20414641
Pennisi P et al. Low bone density and abnormal bone turnover in patients with atherosclerosis of peripheral vessels. 2004 Osteoporos Int pmid:14661073
Jørgensen L et al. Bone loss in relation to serum levels of osteoprotegerin and nuclear factor-kappaB ligand: the Tromsø Study. 2010 Osteoporos Int pmid:19701599
Ferrari-Lacraz S and Ferrari S Do RANKL inhibitors (denosumab) affect inflammation and immunity? 2011 Osteoporos Int pmid:20571772
Aubin JE and Bonnelye E Osteoprotegerin and its ligand: a new paradigm for regulation of osteoclastogenesis and bone resorption. 2000 Osteoporos Int pmid:11193242
Zhao HY et al. The influence of Lys3Asn polymorphism in the osteoprotegerin gene on bone mineral density in Chinese postmenopausal women. 2005 Osteoporos Int pmid:15782282
Leder BZ and Finkelstein JS Effect of aromatase inhibition on bone metabolism in elderly hypogonadal men. 2005 Osteoporos Int pmid:15856361
Simpson CA et al. Serum levels of sclerostin, Dickkopf-1, and secreted frizzled-related protein-4 are not changed in individuals with high bone mass causing mutations in LRP5. 2014 Osteoporos Int pmid:24927689
Mangiafico RA et al. Increased augmentation index and central aortic blood pressure in osteoporotic postmenopausal women. 2008 Osteoporos Int pmid:17676381
Fiore CE et al. Hepatitis C-associated osteosclerosis (HCAO): report of a new case with involvement of the OPG/RANKL system. 2005 Osteoporos Int pmid:15983730
Maïmoun L et al. In peripubertal girls, artistic gymnastics improves areal bone mineral density and femoral bone geometry without affecting serum OPG/RANKL levels. 2011 Osteoporos Int pmid:21359671
Nakashima A et al. Osteoprotegerin and bone mineral density in hemodialysis patients. 2006 Osteoporos Int pmid:16604298
Riggs BL et al. Evidence that type I osteoporosis results from enhanced responsiveness of bone to estrogen deficiency. 2003 Osteoporos Int pmid:12879223

Table of Content